Related Experiment Video
Updated: Jun 17, 2026

An Enzyme- and Serum-free Neural Stem Cell Culture Model for EMT Investigation Suited for Drug Discovery
Published on: August 23, 2016
TNF-alpha modulates the migratory response of mesenchymal stem cells to TRAIL
Federica Corallini1, Paola Secchiero, Antonio Paolo Beltrami
1Department of Morphology and Embryology, University of Ferrara, Ferrara, Italy.
Insights
Lower circulating mesenchymal stem cells (MSC) and higher tumor necrosis factor-alpha (TNF-alpha) and osteoprotegerin (OPG) levels were observed in acute myocardial infarction (AMI) patients who developed heart failure (HF). TNF-alpha
Area of Science:
- Cardiovascular Biology
- Stem Cell Biology
- Immunology
Background:
- Mesenchymal stem cells (MSCs) play a crucial role in cardiac repair after myocardial infarction (MI).
- Reduced MSC levels post-MI are associated with adverse outcomes like heart failure (HF).
- Circulating factors influencing MSC behavior after MI require further investigation.
Purpose of the Study:
- To investigate the relationship between circulating MSCs, TNF-alpha, OPG, and the development of HF after acute myocardial infarction (AMI).
- To elucidate the in vitro effects of TNF-alpha and OPG on MSC migration in the context of AMI.
Main Methods:
- Analysis of circulating MSC counts, TNF-alpha, and OPG levels in AMI patients with and without subsequent HF.
- In vitro experiments assessing MSC migration in response to TNF-related apoptosis-inducing ligand (TRAIL) under varying conditions of TNF-alpha and OPG exposure.
- Assessment of OPG release from endothelial cells upon TNF-alpha stimulation.
Main Results:
- AMI patients who developed HF had significantly lower circulating MSC counts compared to those who did not develop HF.
- Elevated circulating levels of TNF-alpha and OPG were found in AMI patients who subsequently developed HF.
- In vitro, TNF-alpha enhanced MSC migration induced by TRAIL but also increased OPG release from endothelial cells.
- OPG dose-dependently inhibited the pro-migratory effect of TRAIL on MSCs.
Conclusions:
- TNF-alpha has dual, opposing effects on MSC migration post-AMI: it can enhance migration directly but also inhibit it indirectly via OPG induction.
- Elevated OPG levels, induced by TNF-alpha, may counteract the beneficial pro-migratory effects of TRAIL, leading to suboptimal MSC recruitment.
- This complex interplay may contribute to the reduced MSC recruitment observed in AMI patients who develop HF.
Abstract:
The number of circulating mesenchymal stem cells (MSC), analyzed after acute myocardial infarction (AMI), was lower in AMI patients who developed heart failure (HF) in the follow-up. Conversely, the circulating levels of tumor necrosis factor (TNF)-alpha, and osteoprotegerin (OPG) were higher in AMI patients who developed HF with respect to the patients who did not develop HF. In vitro exposure to TNF-alpha enhanced the migration of MSC in response to TNF-related apoptosis-inducing ligand (TRAIL) and significantly increased the release of OPG by endothelial cells. On the contrary, OPG dose-dependently neutralized the in vitro pro-migratory activity of TRAIL. Thus, TNF-alpha exhibits opposite effects on MSC migration driven by TRAIL: it is capable of potentiating MSC migration as well as of inhibiting MSC migration as an indirect consequence of OPG induction, which might result in a suboptimal recruitment of circulating MSC after AMI in those patients who develop HF in the follow-up.
More Related Videos
Related Concept Videos
Mesenchymal Stem Cells
Cell Migration
Cell Migration
Stem Cell Niche
Chemotaxis and Direction of Cell Migration
TGF - β Signaling Pathway

